Nom du produit:3-methyl-2-[4-(3-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)quinoxaline
IUPAC Name:2-{3'-methanesulfonyl-[1,1'-biphenyl]-4-yl}-3-methyl-5-(trifluoromethyl)quinoxaline
- CAS:1221265-37-7
- Formule moléculaire:C23H17F3N2O2S
- Pureté:95%+
- Numéro de catalogue:CM745435
- Poids moléculaire:442.46
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1221265-37-7
- Formule moléculaire:C23H17F3N2O2S
- Point de fusion:-
- Code SMILES:CC1=C(N=C2C=CC=C(C2=N1)C(F)(F)F)C1=CC=C(C=C1)C1=CC(=CC=C1)S(C)(=O)=O
- Densité:
- Numéro de catalogue:CM745435
- Poids moléculaire:442.46
- Point d'ébullition:
- N° Mdl:MFCD18206803
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.